FTH FTH
Company Profile ↓Company Overview
FTH (FTH) is a publicly traded company listed on with a market capitalization of $31.02M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.08.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +184.28% |
| 6 Months: | +171.26% |
| 3 Months: | -4.91% |
| 1 Month: | -5.82% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)43.10 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 32.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -4.10M | -4.91M | -5.36M | -7.97M | -9.78M | -10.32M | -12.49M | -10.71M | -13.94M | -11.01M | -10.18M | -7.74M | -8.73M | -7.79M | -7.82M | -7.27M | -5.21M | -4.85M | -170.63M |
| Net Income | -4.69M | -4.91M | -5.37M | -7.97M | -9.77M | -9.69M | -12.40M | -10.54M | -13.42M | -10.18M | -9.39M | -7.12M | -7.99M | -7.14M | -7.25M | -6.86M | -4.94M | -4.57M | -170.24M |
| Diluted EPS | - | - | - | - | - | -0.32 | -0.40 | -0.34 | -0.44 | -0.33 | -0.31 | -0.28 | -0.32 | -5.69 | -5.77 | -5.45 | -3.91 | -3.62 | -131.45 |
| R&D Expense | 2.19M | - | - | 3.37M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Income | -19.45M | -37.48M | -50.19M | -37.06M | -32.61M | -22.29M |
| Net Income | -20.10M | -36.79M | -48.59M | -34.10M | -30.16M | -21.09M |
| Diluted EPS | - | -1.33 | -1.58 | -1.22 | -24.01 | -16.72 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 21.43M | - | 118.38M | 74.37M | 45.36M | 22.90M |
| Current Assets | - | - | - | 108.59M | 67.25M | 41.93M | 21.51M |
| Cash & Equivalents | - | 16.60M | - | 17.80M | 13.01M | 9.99M | 8.67M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - |
| Total Liabilities | - | 5.54M | - | 14.97M | 9.48M | 6.97M | 4.31M |
| Current Liabilities | - | 4.83M | - | 9.07M | 5.64M | 5.45M | 4.25M |
| Long Term Debt | - | 567.00K | - | - | - | - | - |
| Total Debt | - | - | - | 8.03M | 6.21M | 3.85M | 1.51M |
| Total Equity | -68.66M | -56.44M | - | 103.41M | 64.89M | 38.39M | 18.59M |
| Shares Outstanding | - | - | - | 1.54M | 1.25M | 1.26M | 1.26M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -17.70M | -30.26M | -39.03M | -32.02M | -24.67M | -20.45M |
| Investing Cash Flow | -1.40M | -143.12M | 49.95M | 38.41M | 22.44M | 19.77M |
| Financing Cash Flow | 35.45M | 163.94M | -287.00K | -11.17M | -787.00K | -645.00K |
| Capital Expenditure | -1.21M | -2.03M | -321.00K | -180.00K | -146.00K | -16.00K |
| Free Cash Flow | -18.91M | -32.28M | -39.35M | -32.20M | -24.82M | -20.47M |
| Share Buybacks | - | - | - | 10.38M | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | 35.6% | - | -47.0% | -52.5% | -78.6% | -113.4% |
| ROCE % | -117.2% | - | -45.9% | -53.9% | -81.7% | -119.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for FTH
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBQdDMzR3BSYlVDTVp4STBMZm91NGdxbUhETi1IYVI3OE1jSk4tTF83MTF5V1kxeFJvWWJQazEzT1pJVWZGUmlpSFlVSm9zQ3M?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <font…
$FTH stock is up 8% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxObFN0YjBxWDl2eERzc2Z6ZDNDZmZ6dGpFdXRtTFVDVnBJRWNGQVNsdjlXOUJXaHZfcTkyVnhNS3FPVTlPSUdhZDl4cS1KZHZyWWpmQ0xBRE1JWlhfMXF4TGdMYU5xWmtITVgwRjhsTFNldGNMejVvVnFQd3pqZDBzY0xINS1qVFVxWF9DbG…
Two Faeth New Hires Receive Options With a $28.19 Exercise Price - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOZkdlNWZQZkhFMkxvc3BEaGVxbHRYaFR6cTdBa2E4c3ZlRUhaU0VMMDNQREZaRTRabXM0cGs0RGhZaW9XNlV2U21QZmdmMEhVTEtObmI4WDBGdXpTajNINENGajdpazQxYlhiZVctd1NaZnFyUnUzSVZXV2VndnpQSzBvdzd4cU5CQVdCQ0…
This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
<a href="https://news.google.com/rss/articles/CBMihwJBVV95cUxOWkZfNEJ5SXNaOVNucWdldlJQb1JvbGRPUXYzd3Fvd1c5RGVWVk9icURkMWtGSEl5eWpnUUdFSDJySDFNN1ZkU2NoMThOc2EtTDZzS2U5SWFYaGlNazZaak5STFlUSTI2NGlucHp6UEx0MXB5QVBCa1Ezdk51RWtldVpGSl9xd1ptRmpGV3…
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates - financialcontent.com
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxPb0xabktTaHFDSDlqWEFvcFpqaWpRTXY1UGk5ZFM4Mk5TaFJTTmVzYUhlYndISkU0TkwwWUZDNzBHY1ItMzZNZkhEdnJhOERoX2FwdzQxYXRuSXdrUWRvZW5zRFJiR09NX0Z1VVBFYkRNU2ZoX1p3UUVtUnVmNTVodHJiWGhRY1J4eDFpV1…
Raymond James initiates Faeth Therapeutics stock with outperform rating By Investing.com - Investing.com South Africa
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNY0J2ZGNxclp5bXkyN3pvU1J6bEJkVHJvcHQybVVfcXN3MFAyRVkyQmZHaVBRVGxnVlVfeTZsbklaVG9ZekRKcGExbzhRaUxLanB3eHd5S2F0RFVLQnpKSGFDNTlWX2NQdzhUdTQzOUxjSkt4dGpLV0VFelRyZ2NSOWpFOGtna2Y1VTZZVH…
FTH — Frequently Asked Questions
What is the current share price of FTH?
As of 2026-08-05 17:25 PDT, FTH trades at $24.59 on NASDAQ/NYSE. Its 52-week range is $7.21 to $36.16.
What is the market capitalisation of FTH?
FTH has a market capitalisation of $31.02M on NASDAQ/NYSE.
What is the P/E ratio of FTH?
FTH trades at a trailing price-to-earnings (P/E) ratio of -1.47. Its price-to-book (P/B) ratio is 1.67.
What is the return on equity (ROE) of FTH?
FTH has a return on equity (ROE) of -113.41%. Its return on capital employed (ROCE) is -119.50%.
Is FTH a good stock to buy?
This page provides a data-driven analysis of FTH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.